{"bill":{"bill_id":1366480,"change_hash":"dde87d61d1f16bd9b31c2cb55c7253fd","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB6925\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/6925\/all-info","completed":0,"status":1,"status_date":"2020-05-19","progress":[{"date":"2020-05-19","event":1},{"date":"2020-05-19","event":9}],"state":"US","state_id":52,"bill_number":"HB6925","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Medical Innovation Acceleration Act of 2020","description":"Exempts non-invasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines non-invasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.","pending_committee_id":2302,"committee":{"committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},"referrals":[{"date":"2020-05-19","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"}],"history":[{"date":"2020-05-19","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2020-05-19","action":"Referred to the House Committee on Energy and Commerce.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":18291,"person_hash":"3fg4gjfb","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"Andy Biggs","first_name":"Andy","middle_name":"","last_name":"Biggs","suffix":"","nickname":"","district":"HD-AZ-5","ftm_eid":6602301,"votesmart_id":28088,"opensecrets_id":"N00039293","knowwho_pid":212155,"ballotpedia":"Andy_Biggs","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13304,"subject_name":"Health"},{"subject_id":13384,"subject_name":"Administrative remedies"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13787,"subject_name":"Food and Drug Administration (FDA)"}],"texts":[{"doc_id":2193104,"date":"2020-06-13","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB6925\/id\/2193104","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr6925\/BILLS-116hr6925ih.pdf","text_size":306175,"text_hash":"9a75c33ea946a2db8c1a40f37446907a"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}